세디라닙 단독 및 올라파립 단독과 비교하여 올라파립 및 세디라닙을 테스트한 연구의 초기 단계에 이어 재발성 또는 불응성 자궁내막암에서 올라파립 및 두르발루맙, 세디라닙 및 두르발루맙, 올라파립 및 카피바서팁, 세디라닙 단독 병용 및 올라파립 단독 테스트
재발성, 지속성 또는 전이성 자궁내막암. 재발성 또는 지속성 자궁내막암이 있는 여성을 위한 다군 시험
This phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating patients with endometrial cancer that has come back (recurrent) or does not respond to treatment (refractory). Olaparib, cediranib, and capivasertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Testing the combinations may lower the chance of endometrial cancer growing or spreading compared to usual care.
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
PRIMARY OBJECTIVES:
I. To compare the efficacy of single-agent olaparib and the combination of olaparib and cediranib (and potentially other combination arms that may be added by subsequent amendment) versus single agent cediranib as measured by progression free survival (PFS), in patients with recurrent, persistent or metastatic endometrial cancer.
II. To compare the efficacy of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736) versus single agent cediranib as measured by progression free survival (PFS), in patients with recurrent, persistent or metastatic endometrial cancer.
SECONDARY OBJECTIVES:
I. To compare the efficacy of single-agent olaparib and the combination of olaparib and cediranib (and potentially other combination arms that may be added by subsequent amendment) versus single-agent cediranib as measured by overall survival (OS) in patients with recurrent, persistent or metastatic endometrial cancer.
II. To compare the efficacy of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736) versus single agent cediranib as measured by overall survival (OS), in patients with recurrent, persistent or metastatic endometrial cancer.
III. To compare the efficacy of single-agent olaparib and the combination of olaparib and cediranib (and potentially other combination arms may be added by subsequent amendment versus single-agent cediranib as measured by response rate in patients with recurrent, persistent or metastatic endometrial cancer.
IV. To compare the efficacy of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736) versus single agent cediranib as measured by response rate in patients with recurrent, persistent or metastatic endometrial cancer.
V. To assess the safety and tolerability of single-agent cediranib, single-agent olaparib, and the combination of olaparib and cediranib (and potentially other combination arms may be added by subsequent amendment).
VI. To assess the safety and tolerability of the combination of olaparib and AZD5363 (capivasertib), and the combination of olaparib and durvalumab (MEDI4736), and the combination of cediranib and durvalumab (MEDI4736).
VII. To assess if mutations in deoxyribonucleic acid (DNA) homologous repair genes (assayed prior to all treatment and prior to the study treatment) are predictive of response to olaparib alone or in combination with cediranib. (Integrated Biomarker) VIII. To assess if markers of angiogenesis in serial plasma samples are associated with response to cediranib alone or in combination with olaparib. (Integrated Biomarker)
EXPLORATORY OBJECTIVE:
I. To compare the efficacy of the combination of olaparib and cediranib versus single agent olaparib as measured by PFS, response rate and OS, if and only if the combination is superior to the single-agent cediranib arm.
OUTLINE: Patients are randomized to 1 of 6 arms.
ARM I: Patients in reference group 1 receive cediranib maleate orally (PO) once daily (QD). Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, computed tomography (CT), echocardiography (Echo) or multigated acquisition scan (MUGA) on study.
ARM II: Patients receive olaparib PO twice daily (BID). Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM III: Patients receive olaparib PO BID and cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM IV: Patients receive olaparib PO BID on days 1-28 and capivasertib PO BID on days 1-4 each week. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM V: Patients receive olaparib PO BID on days 1-28 and durvalumab intravenously (IV) on day 1. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM VI: Patients receive cediranib maleate PO QD on days 1-5 each week and durvalumab IV on day 1 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
ARM VII: Patients in reference group 1 receive cediranib maleate PO QD during 08/16/2021 - 06/28/2023). Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study.
After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.
연구 유형
연구 유형
등록 (실제)
등록
단계
단계
- 2 단계
연락처 및 위치
연구 장소
-
-
Alabama
-
Birmingham, Alabama, 미국, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Alaska
-
Anchorage, Alaska, 미국, 98508
- Anchorage Associates in Radiation Medicine
-
Anchorage, Alaska, 미국, 99508
- Alaska Breast Care and Surgery LLC
-
Anchorage, Alaska, 미국, 99508
- Alaska Oncology and Hematology LLC
-
Anchorage, Alaska, 미국, 99508
- Alaska Women's Cancer Care
-
Anchorage, Alaska, 미국, 99508
- Anchorage Oncology Centre
-
Anchorage, Alaska, 미국, 99508
- Katmai Oncology Group
-
Anchorage, Alaska, 미국, 99508
- Providence Alaska Medical Center
-
Anchorage, Alaska, 미국, 99504
- Anchorage Radiation Therapy Center
-
Fairbanks, Alaska, 미국, 99701
- Fairbanks Memorial Hospital
-
-
Arizona
-
Goodyear, Arizona, 미국, 85338
- CTCA at Western Regional Medical Center
-
Kingman, Arizona, 미국, 86401
- Kingman Regional Medical Center
-
Phoenix, Arizona, 미국, 85054
- Mayo Clinic Hospital in Arizona
-
Phoenix, Arizona, 미국, 85004
- Cancer Center at Saint Joseph's
-
Scottsdale, Arizona, 미국, 85259
- Mayo Clinic in Arizona
-
Tucson, Arizona, 미국, 85704
- University of Arizona Cancer Center-Orange Grove Campus
-
Tucson, Arizona, 미국, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, 미국, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Fort Smith, Arkansas, 미국, 72903
- Mercy Hospital Fort Smith
-
Hot Springs, Arkansas, 미국, 71913
- CHI Saint Vincent Cancer Center Hot Springs
-
Little Rock, Arkansas, 미국, 72205
- University of Arkansas for Medical Sciences
-
-
California
-
Anaheim, California, 미국, 92806
- Kaiser Permanente-Anaheim
-
Arroyo Grande, California, 미국, 93420
- PCR Oncology
-
Arroyo Grande, California, 미국, 93420
- Mission Hope Medical Oncology - Arroyo Grande
-
Auburn, California, 미국, 95602
- Sutter Auburn Faith Hospital
-
Auburn, California, 미국, 95603
- Sutter Cancer Centers Radiation Oncology Services-Auburn
-
Baldwin Park, California, 미국, 91706
- Kaiser Permanente-Baldwin Park
-
Bellflower, California, 미국, 90706
- Kaiser Permanente-Bellflower
-
Berkeley, California, 미국, 94704
- Alta Bates Summit Medical Center-Herrick Campus
-
Beverly Hills, California, 미국, 90211
- Tower Cancer Research Foundation
-
Burbank, California, 미국, 91505
- Providence Saint Joseph Medical Center/Disney Family Cancer Center
-
Burlingame, California, 미국, 94010
- Mills-Peninsula Medical Center
-
Cameron Park, California, 미국, 95682
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
-
Carmichael, California, 미국, 95608
- Mercy San Juan Medical Center
-
Carmichael, California, 미국, 95608
- Mercy Cancer Center - Carmichael
-
Castro Valley, California, 미국, 94546
- Eden Hospital Medical Center
-
Davis, California, 미국, 95616
- Sutter Davis Hospital
-
Elk Grove, California, 미국, 95758
- Mercy Cancer Center - Elk Grove
-
Fontana, California, 미국, 92335
- Kaiser Permanente-Fontana
-
Fremont, California, 미국, 94538
- Palo Alto Medical Foundation-Fremont
-
Harbor City, California, 미국, 90710
- Kaiser Permanente South Bay
-
Irvine, California, 미국, 92618
- Kaiser Permanente-Irvine
-
Los Angeles, California, 미국, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, 미국, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, 미국, 90034
- Kaiser Permanente West Los Angeles
-
Modesto, California, 미국, 95355
- Memorial Medical Center
-
Mountain View, California, 미국, 94040
- Palo Alto Medical Foundation-Camino Division
-
Mountain View, California, 미국, 94040
- Palo Alto Medical Foundation-Gynecologic Oncology
-
Napa, California, 미국, 94558
- Providence Queen of The Valley
-
Novato, California, 미국, 94945
- Sutter Cancer Research Consortium
-
Ontario, California, 미국, 91761
- Kaiser Permanente-Ontario
-
Palo Alto, California, 미국, 94301
- Palo Alto Medical Foundation Health Care
-
Panorama City, California, 미국, 91402
- Kaiser Permanente - Panorama City
-
Riverside, California, 미국, 92505
- Kaiser Permanente-Riverside
-
Rocklin, California, 미국, 95765
- Mercy Cancer Center - Rocklin
-
Roseville, California, 미국, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, 미국, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, 미국, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, 미국, 95816
- Mercy Cancer Center - Sacramento
-
San Diego, California, 미국, 92120
- Kaiser Permanente-San Diego Zion
-
San Diego, California, 미국, 92108
- Kaiser Permanente-Rio San Diego
-
San Francisco, California, 미국, 94115
- California Pacific Medical Center-Pacific Campus
-
San Luis Obispo, California, 미국, 93401
- Pacific Central Coast Health Center-San Luis Obispo
-
San Marcos, California, 미국, 92078
- Kaiser Permanente-San Marcos
-
Santa Cruz, California, 미국, 95065
- Palo Alto Medical Foundation-Santa Cruz
-
Santa Maria, California, 미국, 93444
- Mission Hope Medical Oncology - Santa Maria
-
Santa Rosa, California, 미국, 95403
- Sutter Pacific Medical Foundation
-
Santa Rosa, California, 미국, 95403
- Providence Medical Foundation - Santa Rosa
-
Santa Rosa, California, 미국, 95405
- Providence Santa Rosa Memorial Hospital
-
Sunnyvale, California, 미국, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Torrance, California, 미국, 90505
- Torrance Memorial Physician Network - Cancer Care
-
Vallejo, California, 미국, 94589
- Sutter Solano Medical Center/Cancer Center
-
Woodland, California, 미국, 95695
- Woodland Memorial Hospital
-
Woodland Hills, California, 미국, 91367
- Kaiser Permanente-Woodland Hills
-
-
Colorado
-
Aurora, Colorado, 미국, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Aurora, Colorado, 미국, 80012
- The Medical Center of Aurora
-
Aurora, Colorado, 미국, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, 미국, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, 미국, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Centennial, Colorado, 미국, 80112
- Rocky Mountain Cancer Centers - Centennial
-
Colorado Springs, Colorado, 미국, 80907
- Penrose-Saint Francis Healthcare
-
Colorado Springs, Colorado, 미국, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, 미국, 80907
- Rocky Mountain Cancer Centers-Penrose
-
Colorado Springs, Colorado, 미국, 80920
- Memorial Hospital North
-
Colorado Springs, Colorado, 미국, 80923
- Saint Francis Cancer Center
-
Denver, Colorado, 미국, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, 미국, 80220
- Rose Medical Center
-
Denver, Colorado, 미국, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, 미국, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, 미국, 80204
- Denver Health Medical Center
-
Denver, Colorado, 미국, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, 미국, 80209
- The Women's Imaging Center
-
Denver, Colorado, 미국, 80206
- National Jewish Health-Main Campus
-
Denver, Colorado, 미국, 80220
- Western Surgical Care
-
Denver, Colorado, 미국, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, 미국, 80210
- AdventHealth Porter
-
Durango, Colorado, 미국, 81301
- Mercy Medical Center
-
Durango, Colorado, 미국, 81301
- CommonSpirit Cancer Center Mercy
-
Englewood, Colorado, 미국, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, 미국, 80113
- Swedish Medical Center
-
Englewood, Colorado, 미국, 80113
- Rocky Mountain Cancer Centers - Swedish
-
Englewood, Colorado, 미국, 80113
- The Melanoma and Skin Cancer Institute
-
Fort Collins, Colorado, 미국, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, 미국, 80528
- Cancer Care and Hematology-Fort Collins
-
Golden, Colorado, 미국, 80401
- Mountain Blue Cancer Care Center
-
Golden, Colorado, 미국, 80401
- National Jewish Health-Western Hematology Oncology
-
Grand Junction, Colorado, 미국, 81501
- Saint Mary's Hospital and Regional Medical Center
-
Greeley, Colorado, 미국, 80631
- UCHealth Greeley Hospital
-
Greeley, Colorado, 미국, 80631
- Banner North Colorado Medical Center
-
Lafayette, Colorado, 미국, 80026
- Good Samaritan Hospital - Cancer Centers of Colorado
-
Lakewood, Colorado, 미국, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Lakewood, Colorado, 미국, 80228
- CommonSpirit Saint Anthony Hospital Cancer Center
-
Littleton, Colorado, 미국, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Littleton, Colorado, 미국, 80122
- AdventHealth Littleton
-
Lone Tree, Colorado, 미국, 80124
- Sky Ridge Medical Center
-
Lone Tree, Colorado, 미국, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont, Colorado, 미국, 80501
- Longmont United Hospital
-
Longmont, Colorado, 미국, 80501
- Rocky Mountain Cancer Centers-Longmont
-
Loveland, Colorado, 미국, 80538
- Medical Center of the Rockies
-
Loveland, Colorado, 미국, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Parker, Colorado, 미국, 80138
- Rocky Mountain Cancer Centers-Parker
-
Parker, Colorado, 미국, 80138
- AdventHealth Parker
-
Pueblo, Colorado, 미국, 81004
- Saint Mary Corwin Medical Center
-
Pueblo, Colorado, 미국, 81008
- Rocky Mountain Cancer Centers - Pueblo
-
Thornton, Colorado, 미국, 80260
- Rocky Mountain Cancer Centers-Thornton
-
Thornton, Colorado, 미국, 80260
- National Jewish Health-Northern Hematology Oncology
-
Wheat Ridge, Colorado, 미국, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Derby, Connecticut, 미국, 06418
- Smilow Cancer Hospital-Derby Care Center
-
Fairfield, Connecticut, 미국, 06824
- Smilow Cancer Hospital Care Center-Fairfield
-
Guilford, Connecticut, 미국, 06437
- Smilow Cancer Hospital Care Center - Guilford
-
Hartford, Connecticut, 미국, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
Hartford, Connecticut, 미국, 06102
- Hartford Hospital
-
New Britain, Connecticut, 미국, 06050
- The Hospital of Central Connecticut
-
New Haven, Connecticut, 미국, 06520
- Yale University
-
New Haven, Connecticut, 미국, 06510
- Smilow Cancer Center/Yale-New Haven Hospital
-
North Haven, Connecticut, 미국, 06473
- Yale-New Haven Hospital North Haven Medical Center
-
Torrington, Connecticut, 미국, 06790
- Smilow Cancer Hospital-Torrington Care Center
-
Trumbull, Connecticut, 미국, 06611
- Smilow Cancer Hospital Care Center-Trumbull
-
Waterbury, Connecticut, 미국, 06708
- Smilow Cancer Hospital-Waterbury Care Center
-
Waterford, Connecticut, 미국, 06385
- Smilow Cancer Hospital Care Center - Waterford
-
-
Delaware
-
Lewes, Delaware, 미국, 19958
- Beebe Medical Center
-
Millville, Delaware, 미국, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, 미국, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, 미국, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, 미국, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, 미국, 19718
- Christiana Care Health System-Christiana Hospital
-
Rehoboth Beach, Delaware, 미국, 19971
- Beebe Health Campus
-
Seaford, Delaware, 미국, 19973
- TidalHealth Nanticoke / Allen Cancer Center
-
Wilmington, Delaware, 미국, 19801
- Christiana Care Health System-Wilmington Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, 미국, 20037
- George Washington University Medical Center
-
Washington D.C., District of Columbia, 미국, 20016
- Sibley Memorial Hospital
-
-
Florida
-
Bradenton, Florida, 미국, 34205
- Florida Cancer Specialists - Bradenton Cancer Center
-
Gainesville, Florida, 미국, 32610
- UF Health Cancer Institute - Gainesville
-
Jupiter, Florida, 미국, 33458
- Jupiter Medical Center
-
Pensacola, Florida, 미국, 32504
- Sacred Heart Hospital
-
Sarasota, Florida, 미국, 34239
- Sarasota Memorial Hospital
-
Sarasota, Florida, 미국, 34232
- Florida Cancer Specialists - Sarasota
-
Sarasota, Florida, 미국, 34239
- Florida Cancer Specialists - Sarasota Downtown
-
Venice, Florida, 미국, 34285
- Florida Cancer Specialists - Venice Island
-
Venice, Florida, 미국, 34275
- Florida Cancer Specialists - Venice Pinebrook
-
-
Georgia
-
Atlanta, Georgia, 미국, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, 미국, 30322
- Emory University Hospital/Winship Cancer Institute
-
Atlanta, Georgia, 미국, 30342
- Emory Saint Joseph's Hospital
-
Atlanta, Georgia, 미국, 30303
- Grady Health System
-
Atlanta, Georgia, 미국, 30309
- Piedmont Hospital
-
Fayetteville, Georgia, 미국, 30214
- Piedmont Fayette Hospital
-
Newnan, Georgia, 미국, 30265
- CTCA at Southeastern Regional Medical Center
-
Savannah, Georgia, 미국, 31405
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
-
Savannah, Georgia, 미국, 31404
- Memorial Health University Medical Center
-
Savannah, Georgia, 미국, 31404
- Summit Cancer Care-Memorial
-
Savannah, Georgia, 미국, 31405
- Summit Cancer Care-Candler
-
-
Hawaii
-
Honolulu, Hawaii, 미국, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, 미국, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, 미국, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, 미국, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, 미국, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, 미국, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, 미국, 96817
- Hawaii Cancer Care Inc-Liliha
-
Honolulu, Hawaii, 미국, 96817
- Kuakini Medical Center
-
Honolulu, Hawaii, 미국, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, 미국, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, 미국, 96813
- Island Urology
-
Lihue, Hawaii, 미국, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, 미국, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, 미국, 96701
- Pali Momi Medical Center
-
‘Aiea, Hawaii, 미국, 96701
- Queen's Cancer Center - Pearlridge
-
‘Aiea, Hawaii, 미국, 96701
- The Cancer Center of Hawaii-Pali Momi
-
-
Idaho
-
Boise, Idaho, 미국, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, 미국, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, 미국, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Coeur d'Alene, Idaho, 미국, 83814
- Kootenai Health - Coeur d'Alene
-
Emmett, Idaho, 미국, 83617
- Walter Knox Memorial Hospital
-
Fruitland, Idaho, 미국, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, 미국, 83642
- Idaho Urologic Institute-Meridian
-
Meridian, Idaho, 미국, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, 미국, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, 미국, 83687
- Saint Luke's Cancer Institute - Nampa
-
Post Falls, Idaho, 미국, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
Sandpoint, Idaho, 미국, 83864
- Kootenai Clinic Cancer Services - Sandpoint
-
Twin Falls, Idaho, 미국, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Alton, Illinois, 미국, 62002
- OSF Saint Anthony's Health Center
-
Aurora, Illinois, 미국, 60504
- Rush-Copley Medical Center
-
Barrington, Illinois, 미국, 60010
- Advocate Good Shepherd Hospital
-
Bloomington, Illinois, 미국, 61704
- Illinois CancerCare-Bloomington
-
Bloomington, Illinois, 미국, 61704
- Carle BroMenn Outpatient Center
-
Canton, Illinois, 미국, 61520
- Illinois CancerCare-Canton
-
Carbondale, Illinois, 미국, 62902
- Memorial Hospital of Carbondale
-
Carterville, Illinois, 미국, 62918
- SIH Cancer Institute
-
Carthage, Illinois, 미국, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, 미국, 62801
- Centralia Oncology Clinic
-
Centralia, Illinois, 미국, 62801
- Saint Mary's Hospital
-
Chicago, Illinois, 미국, 60611
- Northwestern University
-
Chicago, Illinois, 미국, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, 미국, 60612
- John H Stroger Jr Hospital of Cook County
-
Chicago, Illinois, 미국, 60657
- Advocate Illinois Masonic Medical Center
-
Chicago, Illinois, 미국, 60612
- Rush MD Anderson Cancer Center
-
Crystal Lake, Illinois, 미국, 60014
- AMG Crystal Lake - Oncology
-
Danville, Illinois, 미국, 61832
- Carle at The Riverfront
-
Decatur, Illinois, 미국, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, 미국, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Dixon, Illinois, 미국, 61021
- Illinois CancerCare-Dixon
-
Downers Grove, Illinois, 미국, 60515
- Advocate Good Samaritan Hospital
-
Effingham, Illinois, 미국, 62401
- Crossroads Cancer Center
-
Effingham, Illinois, 미국, 62401
- Carle Physician Group-Effingham
-
Elgin, Illinois, 미국, 60123
- Advocate Sherman Hospital
-
Eureka, Illinois, 미국, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, 미국, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, 미국, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, 미국, 61401
- Illinois CancerCare-Galesburg
-
Geneva, Illinois, 미국, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, 미국, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Harvey, Illinois, 미국, 60426
- Ingalls Memorial Hospital
-
Hazel Crest, Illinois, 미국, 60429
- Advocate South Suburban Hospital
-
Highland Park, Illinois, 미국, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Hinsdale, Illinois, 미국, 60521
- Sudarshan K Sharma MD Limited-Gynecologic Oncology
-
Kewanee, Illinois, 미국, 61443
- Illinois CancerCare-Kewanee Clinic
-
Lake Forest, Illinois, 미국, 60045
- Northwestern Medicine Lake Forest Hospital
-
Macomb, Illinois, 미국, 61455
- Illinois CancerCare-Macomb
-
Mattoon, Illinois, 미국, 61938
- Carle Physician Group-Mattoon/Charleston
-
Mount Vernon, Illinois, 미국, 62864
- SSM Health Good Samaritan
-
New Lenox, Illinois, 미국, 60451
- UC Comprehensive Cancer Center at Silver Cross
-
Normal, Illinois, 미국, 61761
- Carle Cancer Institute Normal
-
Normal, Illinois, 미국, 61761
- Carle BroMenn Medical Center
-
O'Fallon, Illinois, 미국, 62269
- Cancer Care Center of O'Fallon
-
Oak Lawn, Illinois, 미국, 60453-2699
- Advocate Christ Medical Center
-
Orland Park, Illinois, 미국, 60462
- University of Chicago Medicine-Orland Park
-
Ottawa, Illinois, 미국, 61350
- Illinois CancerCare-Ottawa Clinic
-
Park Ridge, Illinois, 미국, 60068
- Advocate Lutheran General Hospital
-
Pekin, Illinois, 미국, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, 미국, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, 미국, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, 미국, 61354
- Illinois CancerCare-Peru
-
Peru, Illinois, 미국, 61354
- Valley Radiation Oncology
-
Princeton, Illinois, 미국, 61356
- Illinois CancerCare-Princeton
-
Springfield, Illinois, 미국, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, 미국, 62702
- Springfield Clinic
-
Springfield, Illinois, 미국, 62781
- Springfield Memorial Hospital
-
Swansea, Illinois, 미국, 62226
- Southwest Illinois Health Services LLP
-
Urbana, Illinois, 미국, 61801
- Carle Cancer Center
-
Urbana, Illinois, 미국, 61801
- The Carle Foundation Hospital
-
Warrenville, Illinois, 미국, 60555
- Northwestern Medicine Cancer Center Warrenville
-
Washington, Illinois, 미국, 61571
- Illinois CancerCare - Washington
-
Yorkville, Illinois, 미국, 60560
- Rush-Copley Healthcare Center
-
Zion, Illinois, 미국, 60099
- Midwestern Regional Medical Center
-
-
Indiana
-
Crown Point, Indiana, 미국, 46307
- Northwest Cancer Center - Crown Point
-
Dyer, Indiana, 미국, 46311
- Northwest Oncology LLC
-
Fort Wayne, Indiana, 미국, 46805
- Parkview Hospital Randallia
-
Fort Wayne, Indiana, 미국, 46845
- Parkview Regional Medical Center
-
Hobart, Indiana, 미국, 46342
- Northwest Cancer Center - Hobart
-
Hobart, Indiana, 미국, 46342
- Saint Mary Medical Center
-
Indianapolis, Indiana, 미국, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, 미국, 46260
- Ascension Saint Vincent Indianapolis Hospital
-
Indianapolis, Indiana, 미국, 46202
- Sidney and Lois Eskenazi Hospital
-
Indianapolis, Indiana, 미국, 46312
- Saint Catherine Hospital
-
Munster, Indiana, 미국, 46321
- The Community Hospital
-
Munster, Indiana, 미국, 46321
- Women's Diagnostic Center - Munster
-
Richmond, Indiana, 미국, 47374
- Reid Health
-
South Bend, Indiana, 미국, 46601
- Memorial Hospital of South Bend
-
Valparaiso, Indiana, 미국, 46383
- Northwest Cancer Center - Valparaiso
-
-
Iowa
-
Clive, Iowa, 미국, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, 미국, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Council Bluffs, Iowa, 미국, 51503
- Alegent Health Mercy Hospital
-
Creston, Iowa, 미국, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, 미국, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, 미국, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, 미국, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, 미국, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, 미국, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, 미국, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Fort Dodge, Iowa, 미국, 50501
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Iowa City, Iowa, 미국, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
West Des Moines, Iowa, 미국, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, 미국, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Garden City, Kansas, 미국, 67846
- Central Care Cancer Center - Garden City
-
Great Bend, Kansas, 미국, 67530
- Central Care Cancer Center - Great Bend
-
Wichita, Kansas, 미국, 67214
- Ascension Via Christi Hospitals Wichita
-
Wichita, Kansas, 미국, 67208
- Cancer Center of Kansas-Wichita Medical Arts Tower
-
Wichita, Kansas, 미국, 67214
- Cancer Center of Kansas - Wichita
-
Wichita, Kansas, 미국, 67208
- Associates In Womens Health
-
-
Kentucky
-
Bardstown, Kentucky, 미국, 40004
- CommonSpirit Saint Joseph Hospital - Bardstown
-
Corbin, Kentucky, 미국, 40701
- Baptist Health Corbin
-
Corbin, Kentucky, 미국, 40701
- Commonwealth Cancer Center-Corbin
-
Edgewood, Kentucky, 미국, 41017
- Saint Elizabeth Healthcare Edgewood
-
Lexington, Kentucky, 미국, 40504
- Saint Joseph Radiation Oncology Resource Center
-
Lexington, Kentucky, 미국, 40503
- Baptist Health Lexington
-
Lexington, Kentucky, 미국, 40509
- CommonSpirit Saint Joseph Medical Center - East Lexington
-
Lexington, Kentucky, 미국, 40504
- CommonSpirit Saint Joseph Hospital - Lexington
-
London, Kentucky, 미국, 40741
- CommonSpirit Saint Joseph Hospital London
-
Louisville, Kentucky, 미국, 40202
- Jewish Hospital
-
Louisville, Kentucky, 미국, 40245
- UofL Health Medical Center Northeast
-
Louisville, Kentucky, 미국, 40207
- Baptist Health Louisville
-
Louisville, Kentucky, 미국, 40215
- Saints Mary and Elizabeth Hospital
-
Madisonville, Kentucky, 미국, 42431
- Baptist Health Madisonville/Merle Mahr Cancer Center
-
Mount Sterling, Kentucky, 미국, 40353
- CommonSpirit Saint Joseph Hospital Mount Sterling
-
Paducah, Kentucky, 미국, 42003
- Baptist Health Paducah
-
Paducah, Kentucky, 미국, 42003
- Mercy Health - Paducah Cancer Center
-
Richmond, Kentucky, 미국, 40475
- Baptist Health Richmond
-
Shepherdsville, Kentucky, 미국, 40165
- Jewish Hospital Medical Center South
-
-
Louisiana
-
Baton Rouge, Louisiana, 미국, 70809
- Mary Bird Perkins Cancer Center
-
Covington, Louisiana, 미국, 70433
- Women's Cancer Care-Covington
-
New Orleans, Louisiana, 미국, 70121
- Ochsner Medical Center Jefferson
-
New Orleans, Louisiana, 미국, 70115
- Ochsner Baptist Medical Center
-
-
Maine
-
Bangor, Maine, 미국, 04401
- Eastern Maine Medical Center
-
Brewer, Maine, 미국, 04412
- Lafayette Family Cancer Center-EMMC
-
Scarborough, Maine, 미국, 04074
- MaineHealth Maine Medical Center- Scarborough
-
-
Maryland
-
Annapolis, Maryland, 미국, 21401
- Luminis Health Anne Arundel Medical Center
-
Baltimore, Maryland, 미국, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Baltimore, Maryland, 미국, 21204
- Greater Baltimore Medical Center
-
Bethesda, Maryland, 미국, 20889-5600
- Walter Reed National Military Medical Center
-
Easton, Maryland, 미국, 21601
- University of Maryland Shore Medical Center at Easton
-
Elkton, Maryland, 미국, 21921
- Christiana Care - Union Hospital
-
-
Massachusetts
-
Beverly, Massachusetts, 미국, 01915
- Beverly Hospital
-
Burlington, Massachusetts, 미국, 01805
- Lahey Clinic
-
Gloucester, Massachusetts, 미국, 01930
- Addison Gilbert Hospital
-
Peabody, Massachusetts, 미국, 01960
- Lahey Clinic Peabody
-
Springfield, Massachusetts, 미국, 01199
- Baystate Medical Center
-
Winchester, Massachusetts, 미국, 01890
- Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care
-
Worcester, Massachusetts, 미국, 01605
- UMass Memorial Medical Center - Memorial Division
-
-
Michigan
-
Ann Arbor, Michigan, 미국, 48109
- University of Michigan Rogel Cancer Center
-
Brighton, Michigan, 미국, 48116
- University of Michigan - Brighton Center for Specialty Care
-
Detroit, Michigan, 미국, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, 미국, 48334
- Weisberg Cancer Treatment Center
-
Port Huron, Michigan, 미국, 48060
- Lake Huron Medical Center
-
Port Huron, Michigan, 미국, 48060
- Huron Medical Center PC
-
-
Minnesota
-
Aitkin, Minnesota, 미국, 56431
- Riverwood Healthcare Center
-
Baxter, Minnesota, 미국, 56425
- Essentia Health - Baxter Clinic
-
Bemidji, Minnesota, 미국, 56601
- Sanford Joe Lueken Cancer Center
-
Brainerd, Minnesota, 미국, 56401
- Essentia Health Saint Joseph's Medical Center
-
Burnsville, Minnesota, 미국, 55337
- Fairview Ridges Hospital
-
Burnsville, Minnesota, 미국, 55337
- Minnesota Oncology - Burnsville
-
Cambridge, Minnesota, 미국, 55008
- Cambridge Medical Center
-
Coon Rapids, Minnesota, 미국, 55433
- Mercy Hospital
-
Deer River, Minnesota, 미국, 56636
- Essentia Health - Deer River Clinic
-
Detroit Lakes, Minnesota, 미국, 56501
- Essentia Health Saint Mary's - Detroit Lakes Clinic
-
Duluth, Minnesota, 미국, 55805
- Essentia Health Cancer Center
-
Duluth, Minnesota, 미국, 55805
- Essentia Health Saint Mary's Medical Center
-
Duluth, Minnesota, 미국, 55805
- Miller-Dwan Hospital
-
Edina, Minnesota, 미국, 55435
- Fairview Southdale Hospital
-
Ely, Minnesota, 미국, 55731
- Essentia Health - Ely Clinic
-
Fergus Falls, Minnesota, 미국, 56537
- Lake Region Healthcare Corporation-Cancer Care
-
Fosston, Minnesota, 미국, 56542
- Essentia Health - Fosston
-
Fridley, Minnesota, 미국, 55432
- Unity Hospital
-
Hibbing, Minnesota, 미국, 55746
- Essentia Health Hibbing Clinic
-
International Falls, Minnesota, 미국, 56649
- Essentia Health - International Falls Clinic
-
Maple Grove, Minnesota, 미국, 55369
- Fairview Clinics and Surgery Center Maple Grove
-
Maplewood, Minnesota, 미국, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, 미국, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, 미국, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, 미국, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, 미국, 55454
- Health Partners Inc
-
Monticello, Minnesota, 미국, 55362
- Monticello Cancer Center
-
Moose Lake, Minnesota, 미국, 55767
- Essentia Health - Moose Lake Clinic
-
New Ulm, Minnesota, 미국, 56073
- New Ulm Medical Center
-
Park Rapids, Minnesota, 미국, 56470
- Essentia Health - Park Rapids
-
Princeton, Minnesota, 미국, 55371
- Fairview Northland Medical Center
-
Robbinsdale, Minnesota, 미국, 55422
- North Memorial Medical Health Center
-
Rochester, Minnesota, 미국, 55905
- Mayo Clinic in Rochester
-
Saint Louis Park, Minnesota, 미국, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, 미국, 55101
- Regions Hospital
-
Saint Paul, Minnesota, 미국, 55102
- United Hospital
-
Sandstone, Minnesota, 미국, 55072
- Essentia Health Sandstone
-
Shakopee, Minnesota, 미국, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, 미국, 55082
- Lakeview Hospital
-
Thief River Falls, Minnesota, 미국, 56701
- Sanford Thief River Falls Medical Center
-
Virginia, Minnesota, 미국, 55792
- Essentia Health Virginia Clinic
-
Waconia, Minnesota, 미국, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, 미국, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, 미국, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
Worthington, Minnesota, 미국, 56187
- Sanford Cancer Center Worthington
-
Wyoming, Minnesota, 미국, 55092
- Fairview Lakes Medical Center
-
-
Mississippi
-
Jackson, Mississippi, 미국, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Ballwin, Missouri, 미국, 63011
- Mercy Oncology and Hematology - Clayton-Clarkson
-
Bolivar, Missouri, 미국, 65613
- Central Care Cancer Center - Bolivar
-
Bonne Terre, Missouri, 미국, 63628
- Parkland Health Center-Bonne Terre
-
Branson, Missouri, 미국, 65616
- Cox Cancer Center Branson
-
Cape Girardeau, Missouri, 미국, 63703
- Saint Francis Medical Center
-
Cape Girardeau, Missouri, 미국, 63703
- Mercy Cancer Center - Cape Girardeau
-
Columbia, Missouri, 미국, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Farmington, Missouri, 미국, 63640
- Parkland Health Center - Farmington
-
Jefferson City, Missouri, 미국, 65109
- MU Health Care Goldschmidt Cancer Center
-
Joplin, Missouri, 미국, 64804
- Freeman Health System
-
Joplin, Missouri, 미국, 64804
- Mercy Hospital Joplin
-
Rolla, Missouri, 미국, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, 미국, 65401
- Phelps Health Delbert Day Cancer Institute
-
Saint Joseph, Missouri, 미국, 64506
- Heartland Regional Medical Center
-
Sainte Genevieve, Missouri, 미국, 63670
- Sainte Genevieve County Memorial Hospital
-
Springfield, Missouri, 미국, 65807
- CoxHealth South Hospital
-
Springfield, Missouri, 미국, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, 미국, 63110
- Washington University School of Medicine
-
St Louis, Missouri, 미국, 63131
- Missouri Baptist Medical Center
-
St Louis, Missouri, 미국, 63109
- Mercy Infusion Center - Chippewa
-
St Louis, Missouri, 미국, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, 미국, 63128
- Mercy Hospital South
-
Sullivan, Missouri, 미국, 63080
- Missouri Baptist Sullivan Hospital
-
Washington, Missouri, 미국, 63090
- Mercy Hospital Washington
-
-
Montana
-
Anaconda, Montana, 미국, 59711
- Community Hospital of Anaconda
-
Billings, Montana, 미국, 59101
- Billings Clinic Cancer Center
-
Billings, Montana, 미국, 59101
- Saint Vincent Healthcare
-
Billings, Montana, 미국, 59102
- Saint Vincent Frontier Cancer Center
-
Bozeman, Montana, 미국, 59715
- Bozeman Health Deaconess Hospital
-
Butte, Montana, 미국, 59701
- Saint James Community Hospital and Cancer Treatment Center
-
Great Falls, Montana, 미국, 59405
- Great Falls Clinic
-
Great Falls, Montana, 미국, 59405
- Benefis Sletten Cancer Institute
-
Helena, Montana, 미국, 59601
- Saint Peter's Community Hospital
-
Kalispell, Montana, 미국, 59901
- Logan Health Medical Center
-
Missoula, Montana, 미국, 59802
- Saint Patrick Hospital - Community Hospital
-
Missoula, Montana, 미국, 59804
- Community Medical Center
-
-
Nebraska
-
Grand Island, Nebraska, 미국, 68803
- Nebraska Cancer Specialists/Oncology Hematology West PC
-
Kearney, Nebraska, 미국, 68847
- CHI Health Good Samaritan
-
Kearney, Nebraska, 미국, 68845
- Fred and Pamela Buffett Cancer Center - Kearney
-
Lincoln, Nebraska, 미국, 68510
- Saint Elizabeth Regional Medical Center
-
Omaha, Nebraska, 미국, 68114
- Nebraska Methodist Hospital
-
Omaha, Nebraska, 미국, 68198
- University of Nebraska Medical Center
-
Omaha, Nebraska, 미국, 68124
- Alegent Health Bergan Mercy Medical Center
-
Omaha, Nebraska, 미국, 68118
- Nebraska Medicine-Village Pointe
-
Omaha, Nebraska, 미국, 68122
- Alegent Health Immanuel Medical Center
-
Omaha, Nebraska, 미국, 68130
- Alegent Health Lakeside Hospital
-
Omaha, Nebraska, 미국, 68122
- Hematology and Oncology Consultants PC
-
Omaha, Nebraska, 미국, 68114
- Oncology Associates PC
-
Omaha, Nebraska, 미국, 68114
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC
-
Papillion, Nebraska, 미국, 68046
- Midlands Community Hospital
-
-
Nevada
-
Carson City, Nevada, 미국, 89703
- Carson Tahoe Regional Medical Center
-
Henderson, Nevada, 미국, 89052
- Comprehensive Cancer Centers of Nevada - Henderson
-
Henderson, Nevada, 미국, 89052
- Cancer and Blood Specialists-Henderson
-
Henderson, Nevada, 미국, 89052
- Las Vegas Cancer Center-Henderson
-
Henderson, Nevada, 미국, 89074
- Comprehensive Cancer Centers of Nevada-Southeast Henderson
-
Henderson, Nevada, 미국, 89052
- Comprehensive Cancer Centers of Nevada-Horizon Ridge
-
Henderson, Nevada, 미국, 89074
- Las Vegas Urology - Green Valley
-
Henderson, Nevada, 미국, 89074
- Las Vegas Urology - Pebble
-
Henderson, Nevada, 미국, 89074
- Urology Specialists of Nevada - Green Valley
-
Henderson, Nevada, 미국, 89074
- Oncology Las Vegas - Henderson
-
Las Vegas, Nevada, 미국, 89144
- Summerlin Hospital Medical Center
-
Las Vegas, Nevada, 미국, 89109
- Sunrise Hospital and Medical Center
-
Las Vegas, Nevada, 미국, 89102
- OptumCare Cancer Care at Charleston
-
Las Vegas, Nevada, 미국, 89106
- Radiation Oncology Centers of Nevada Central
-
Las Vegas, Nevada, 미국, 89119
- Radiation Oncology Centers of Nevada Southeast
-
Las Vegas, Nevada, 미국, 89128
- Comprehensive Cancer Centers of Nevada - Northwest
-
Las Vegas, Nevada, 미국, 89128
- OptumCare Cancer Care at MountainView
-
Las Vegas, Nevada, 미국, 89135
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation
-
Las Vegas, Nevada, 미국, 89144
- Comprehensive Cancer Centers of Nevada - Town Center
-
Las Vegas, Nevada, 미국, 89144
- Comprehensive Cancer Centers of Nevada-Summerlin
-
Las Vegas, Nevada, 미국, 89148
- Comprehensive Cancer Centers of Nevada
-
Las Vegas, Nevada, 미국, 89169
- Comprehensive Cancer Centers of Nevada - Central Valley
-
Las Vegas, Nevada, 미국, 89106
- Women's Cancer Center of Nevada
-
Las Vegas, Nevada, 미국, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, 미국, 89106
- Cancer and Blood Specialists-Shadow
-
Las Vegas, Nevada, 미국, 89109
- HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway
-
Las Vegas, Nevada, 미국, 89113
- HealthCare Partners Medical Group Oncology/Hematology-San Martin
-
Las Vegas, Nevada, 미국, 89128
- Cancer and Blood Specialists-Tenaya
-
Las Vegas, Nevada, 미국, 89128
- HealthCare Partners Medical Group Oncology/Hematology-Tenaya
-
Las Vegas, Nevada, 미국, 89148-2405
- Las Vegas Cancer Center-Medical Center
-
Las Vegas, Nevada, 미국, 89149
- HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills
-
Las Vegas, Nevada, 미국, 89128
- Ann M Wierman MD LTD
-
Las Vegas, Nevada, 미국, 89074
- Las Vegas Urology - Pecos
-
Las Vegas, Nevada, 미국, 89102
- Desert West Surgery
-
Las Vegas, Nevada, 미국, 89103
- Hope Cancer Care of Nevada
-
Las Vegas, Nevada, 미국, 89106
- Urology Specialists of Nevada - Central
-
Las Vegas, Nevada, 미국, 89113
- Las Vegas Prostate Cancer Center
-
Las Vegas, Nevada, 미국, 89113
- Las Vegas Urology - Sunset
-
Las Vegas, Nevada, 미국, 89128
- Las Vegas Urology - Cathedral Rock
-
Las Vegas, Nevada, 미국, 89128
- Las Vegas Urology - Smoke Ranch
-
Las Vegas, Nevada, 미국, 89128
- Urology Specialists of Nevada - Northwest
-
Las Vegas, Nevada, 미국, 89169
- University Cancer Center
-
Las Vegas, Nevada, 미국, 89113
- Urology Specialists of Nevada - Southwest
-
Las Vegas, Nevada, 미국, 89128
- Oncology Las Vegas - Tenaya
-
Las Vegas, Nevada, 미국, 89183
- OptumCare Cancer Care at Fort Apache
-
Pahrump, Nevada, 미국, 89048
- Hope Cancer Care of Nevada-Pahrump
-
Reno, Nevada, 미국, 89502
- Renown Regional Medical Center
-
Reno, Nevada, 미국, 89503
- Saint Mary's Regional Medical Center
-
Reno, Nevada, 미국, 89509
- Radiation Oncology Associates
-
-
New Hampshire
-
Lebanon, New Hampshire, 미국, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
Manchester, New Hampshire, 미국, 03104
- Dartmouth Cancer Center - Manchester/ DCC Manchester
-
Nashua, New Hampshire, 미국, 03063
- Dartmouth Cancer Center - Nashua
-
-
New Jersey
-
Mount Holly, New Jersey, 미국, 08060
- Virtua Memorial
-
Voorhees Township, New Jersey, 미국, 08043
- Virtua Voorhees
-
-
New Mexico
-
Albuquerque, New Mexico, 미국, 87106
- Southwest Gynecologic Oncology Associates Inc
-
Albuquerque, New Mexico, 미국, 87106
- University of New Mexico Cancer Center
-
Rio Rancho, New Mexico, 미국, 87124
- Presbyterian Rust Medical Center/Jorgensen Cancer Center
-
-
New York
-
Albany, New York, 미국, 12208
- Women's Cancer Care Associates LLC
-
Buffalo, New York, 미국, 14263
- Roswell Park Cancer Institute
-
New York, New York, 미국, 10029
- Mount Sinai Hospital
-
New York, New York, 미국, 10011
- Mount Sinai Chelsea
-
New York, New York, 미국, 10016
- Laura and Isaac Perlmutter Cancer Center at NYU Langone
-
Rochester, New York, 미국, 14642
- University of Rochester
-
The Bronx, New York, 미국, 10461
- Montefiore Medical Center-Einstein Campus
-
The Bronx, New York, 미국, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, 미국, 10461
- Montefiore Medical Center-Weiler Hospital
-
White Plains, New York, 미국, 10601
- Dickstein Cancer Treatment Center
-
-
North Carolina
-
Asheboro, North Carolina, 미국, 27203
- Randolph Hospital
-
Asheville, North Carolina, 미국, 28816
- Hope Women's Cancer Centers-Asheville
-
Burlington, North Carolina, 미국, 27215
- Cone Health Cancer Center at Alamance Regional
-
Cary, North Carolina, 미국, 27518
- Duke Cancer Center Cary
-
Chapel Hill, North Carolina, 미국, 27599
- UNC Lineberger Comprehensive Cancer Center
-
Charlotte, North Carolina, 미국, 28204
- Novant Health Presbyterian Medical Center
-
Charlotte, North Carolina, 미국, 28207
- Oncology Specialists of Charlotte
-
Charlotte, North Carolina, 미국, 28262
- Southern Oncology Specialists-Charlotte
-
Charlotte, North Carolina, 미국, 28207
- Novant Health Carolina Surgical - Randolph
-
Clinton, North Carolina, 미국, 28328
- Southeastern Medical Oncology Center-Clinton
-
Durham, North Carolina, 미국, 27710
- Duke University Medical Center
-
Goldsboro, North Carolina, 미국, 27534
- Southeastern Medical Oncology Center-Goldsboro
-
Goldsboro, North Carolina, 미국, 27534
- Wayne Memorial Hospital
-
Greensboro, North Carolina, 미국, 27403
- Cone Health Cancer Center
-
Huntersville, North Carolina, 미국, 28078
- Novant Health Cancer Institute - Huntersville
-
Huntersville, North Carolina, 미국, 28078
- Southern Oncology Specialists-Huntersville
-
Huntersville, North Carolina, 미국, 28078
- Novant Health Presbyterian Medical Center Huntersville
-
Jacksonville, North Carolina, 미국, 28546
- Southeastern Medical Oncology Center-Jacksonville
-
Jacksonville, North Carolina, 미국, 28546
- Onslow Memorial Hospital
-
Kernersville, North Carolina, 미국, 27284
- Novant Health Cancer Institute - Kernersville
-
Matthews, North Carolina, 미국, 28105
- Matthews Radiation Oncology Center
-
Matthews, North Carolina, 미국, 28105
- Novant Health Cancer Institute - Matthews
-
Mebane, North Carolina, 미국, 27302
- Cone Heath Cancer Center at Mebane
-
Mooresville, North Carolina, 미국, 28117
- Novant Health Cancer Institute - Mooresville
-
Mount Airy, North Carolina, 미국, 27030
- Novant Health Cancer Institute - Mount Airy
-
North Wilkesboro, North Carolina, 미국, 28659
- Novant Health Cancer Institute - Wilkesboro
-
Raleigh, North Carolina, 미국, 27607
- Duke Women's Cancer Care Raleigh
-
Raleigh, North Carolina, 미국, 27609
- Duke Cancer Center Raleigh
-
Reidsville, North Carolina, 미국, 27320
- Annie Penn Memorial Hospital
-
Salisbury, North Carolina, 미국, 28144
- Novant Health Cancer Institute - Rowan
-
Salisbury, North Carolina, 미국, 28144
- Rowan Regional Medical Center
-
Statesville, North Carolina, 미국, 28625
- Novant Health Cancer Institute - Statesville
-
Thomasville, North Carolina, 미국, 27360
- Novant Health Cancer Institute - Thomasville
-
Winston-Salem, North Carolina, 미국, 27103
- Novant Health Forsyth Medical Center
-
Winston-Salem, North Carolina, 미국, 27103
- Novant Health Oncology Specialists
-
-
North Dakota
-
Bismarck, North Dakota, 미국, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, 미국, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, 미국, 58103
- Essentia Health Cancer Center-South University Clinic
-
Fargo, North Dakota, 미국, 58122
- Sanford Broadway Medical Center
-
Fargo, North Dakota, 미국, 58103
- Sanford South University Medical Center
-
Fargo, North Dakota, 미국, 58104
- Sanford Medical Center Fargo
-
Jamestown, North Dakota, 미국, 58401
- Essentia Health - Jamestown Clinic
-
-
Ohio
-
Akron, Ohio, 미국, 44304
- Summa Health System - Akron Campus
-
Alliance, Ohio, 미국, 44601
- Aultman Alliance Community Hospital
-
Beachwood, Ohio, 미국, 44122
- UHHS-Chagrin Highlands Medical Center
-
Beavercreek, Ohio, 미국, 45431
- Indu and Raj Soin Medical Center
-
Belpre, Ohio, 미국, 45714
- Strecker Cancer Center-Belpre
-
Boardman, Ohio, 미국, 44512
- Saint Elizabeth Boardman Hospital
-
Canton, Ohio, 미국, 44710
- Aultman Health Foundation
-
Centerville, Ohio, 미국, 45459
- Miami Valley Hospital South
-
Centerville, Ohio, 미국, 45459
- Dayton Physicians LLC-Miami Valley South
-
Chardon, Ohio, 미국, 44024
- Geauga Hospital
-
Chillicothe, Ohio, 미국, 45601
- Adena Regional Medical Center
-
Cincinnati, Ohio, 미국, 45220
- Good Samaritan Hospital - Cincinnati
-
Cincinnati, Ohio, 미국, 45242
- Bethesda North Hospital
-
Cincinnati, Ohio, 미국, 45236
- Oncology Hematology Care Inc-Kenwood
-
Cincinnati, Ohio, 미국, 45247
- TriHealth Cancer Institute-Westside
-
Cincinnati, Ohio, 미국, 45255
- TriHealth Cancer Institute-Anderson
-
Cleveland, Ohio, 미국, 44106
- Case Western Reserve University
-
Cleveland, Ohio, 미국, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, 미국, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, 미국, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, 미국, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, 미국, 43210
- Ohio State University Comprehensive Cancer Center
-
Columbus, Ohio, 미국, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, 미국, 43214
- Columbus Oncology and Hematology Associates Inc
-
Columbus, Ohio, 미국, 43228
- Doctors Hospital
-
Columbus, Ohio, 미국, 43213
- Mount Carmel East Hospital
-
Columbus, Ohio, 미국, 43215
- Grant Medical Center
-
Columbus, Ohio, 미국, 43222
- Mount Carmel Health Center West
-
Dayton, Ohio, 미국, 45406
- Good Samaritan Hospital - Dayton
-
Dayton, Ohio, 미국, 45409
- Miami Valley Hospital
-
Dayton, Ohio, 미국, 45415
- Miami Valley Hospital North
-
Dayton, Ohio, 미국, 45415
- Dayton Physician LLC - Englewood
-
Delaware, Ohio, 미국, 43015
- Delaware Health Center-Grady Cancer Center
-
Delaware, Ohio, 미국, 43015
- Delaware Radiation Oncology
-
Delaware, Ohio, 미국, 43015
- Grady Memorial Hospital
-
Dublin, Ohio, 미국, 43016
- Columbus Oncology and Hematology Associates
-
Elyria, Ohio, 미국, 44035
- Mercy Cancer Center-Elyria
-
Findlay, Ohio, 미국, 45840
- Blanchard Valley Hospital
-
Findlay, Ohio, 미국, 45840
- Armes Family Cancer Center
-
Findlay, Ohio, 미국, 45840
- Orion Cancer Care
-
Franklin, Ohio, 미국, 45005-1066
- Atrium Medical Center-Middletown Regional Hospital
-
Franklin, Ohio, 미국, 45005
- Dayton Physicians LLC-Atrium
-
Gahanna, Ohio, 미국, 43230
- Central Ohio Breast and Endocrine Surgery
-
Greenville, Ohio, 미국, 45331
- Wayne Hospital
-
Greenville, Ohio, 미국, 45331
- Dayton Physicians LLC-Wayne
-
Grove City, Ohio, 미국, 43123
- Mount Carmel Grove City Hospital
-
Grove City, Ohio, 미국, 43123
- Zangmeister Center Grove City
-
Kettering, Ohio, 미국, 45429
- Kettering Medical Center
-
Kettering, Ohio, 미국, 45409
- Greater Dayton Cancer Center
-
Kettering, Ohio, 미국, 45420
- First Dayton Cancer Care
-
Lancaster, Ohio, 미국, 43130
- Fairfield Medical Center
-
Lima, Ohio, 미국, 45801
- Saint Rita's Medical Center
-
Mansfield, Ohio, 미국, 44903
- OhioHealth Mansfield Hospital
-
Marietta, Ohio, 미국, 45750
- Marietta Memorial Hospital
-
Marion, Ohio, 미국, 43302
- OhioHealth Marion General Hospital
-
Mayfield Heights, Ohio, 미국, 44124
- Hillcrest Hospital Cancer Center
-
Mentor, Ohio, 미국, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, 미국, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Mount Vernon, Ohio, 미국, 43050
- Knox Community Hospital
-
New Albany, Ohio, 미국, 43054
- Mount Carmel New Albany Surgical Hospital
-
Newark, Ohio, 미국, 43055
- Licking Memorial Hospital
-
Newark, Ohio, 미국, 43055
- Newark Radiation Oncology
-
Perrysburg, Ohio, 미국, 43551
- Mercy Health - Perrysburg Hospital
-
Portsmouth, Ohio, 미국, 45662
- Southern Ohio Medical Center
-
Sandusky, Ohio, 미국, 44870
- UH Seidman Cancer Center at Firelands Regional Medical Center
-
Springfield, Ohio, 미국, 45504
- Springfield Regional Cancer Center
-
Springfield, Ohio, 미국, 45504
- Springfield Regional Medical Center
-
Sylvania, Ohio, 미국, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, 미국, 43606
- ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
-
Toledo, Ohio, 미국, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, 미국, 43608
- Mercy Health - Saint Vincent Hospital
-
Toledo, Ohio, 미국, 43623
- Mercy Health Sylvania Radiation Oncology Center
-
Troy, Ohio, 미국, 45373
- Upper Valley Medical Center
-
Troy, Ohio, 미국, 45373
- Dayton Physicians LLC - Troy
-
Wadsworth, Ohio, 미국, 44281
- University Hospitals Sharon Health Center
-
Warren, Ohio, 미국, 44484
- Saint Joseph Warren Hospital
-
Westerville, Ohio, 미국, 43081
- Saint Ann's Hospital
-
Westlake, Ohio, 미국, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Westlake, Ohio, 미국, 44145
- UHHS-Westlake Medical Center
-
Youngstown, Ohio, 미국, 44501
- Saint Elizabeth Youngstown Hospital
-
Zanesville, Ohio, 미국, 43701
- Genesis Healthcare System Cancer Care Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, 미국, 73120
- Mercy Hospital Oklahoma City
-
Tulsa, Oklahoma, 미국, 74146
- Oklahoma Cancer Specialists and Research Institute-Tulsa
-
-
Oregon
-
Baker City, Oregon, 미국, 97814
- Saint Alphonsus Cancer Care Center-Baker City
-
Bend, Oregon, 미국, 97701
- Saint Charles Health System
-
Clackamas, Oregon, 미국, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, 미국, 97015
- Providence Cancer Institute Clackamas Clinic
-
Coos Bay, Oregon, 미국, 97420
- Bay Area Hospital
-
Newberg, Oregon, 미국, 97132
- Providence Newberg Medical Center
-
Ontario, Oregon, 미국, 97914
- Saint Alphonsus Cancer Care Center-Ontario
-
Oregon City, Oregon, 미국, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, 미국, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, 미국, 97213
- Providence Portland Medical Center
-
Portland, Oregon, 미국, 97225
- Providence Saint Vincent Medical Center
-
Redmond, Oregon, 미국, 97756
- Saint Charles Health System-Redmond
-
Tualatin, Oregon, 미국, 97062
- Legacy Meridian Park Hospital
-
-
Pennsylvania
-
Abington, Pennsylvania, 미국, 19001
- Jefferson Abington Hospital
-
Bryn Mawr, Pennsylvania, 미국, 19010
- Bryn Mawr Hospital
-
Chadds Ford, Pennsylvania, 미국, 19317
- Christiana Care Health System-Concord Health Center
-
Collegeville, Pennsylvania, 미국, 19426
- Main Line Health Center-Collegeville
-
Exton, Pennsylvania, 미국, 19341
- Main Line Health Center-Exton
-
Jefferson Hills, Pennsylvania, 미국, 15025
- Jefferson Hospital
-
Media, Pennsylvania, 미국, 19063
- Riddle Memorial Hospital
-
Monroeville, Pennsylvania, 미국, 15146
- Forbes Hospital
-
Paoli, Pennsylvania, 미국, 19301
- Paoli Memorial Hospital
-
Philadelphia, Pennsylvania, 미국, 19107
- Thomas Jefferson University Hospital
-
Pittsburgh, Pennsylvania, 미국, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, 미국, 15224
- West Penn Hospital
-
West Chester, Pennsylvania, 미국, 19380
- Chester County Hospital
-
West Reading, Pennsylvania, 미국, 19611
- Reading Hospital
-
Wexford, Pennsylvania, 미국, 15090
- Wexford Health and Wellness Pavilion
-
Willow Grove, Pennsylvania, 미국, 19090
- Asplundh Cancer Pavilion
-
Wynnewood, Pennsylvania, 미국, 19096
- Lankenau Medical Center
-
-
Rhode Island
-
Providence, Rhode Island, 미국, 02905
- Women and Infants Hospital
-
-
South Carolina
-
Anderson, South Carolina, 미국, 29621
- AnMed Health Cancer Center
-
Charleston, South Carolina, 미국, 29425
- Medical University of South Carolina
-
Gaffney, South Carolina, 미국, 29341
- Gibbs Cancer Center-Gaffney
-
Greenville, South Carolina, 미국, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, 미국, 29601
- Saint Francis Hospital
-
Greer, South Carolina, 미국, 29651
- Gibbs Cancer Center-Pelham
-
Spartanburg, South Carolina, 미국, 29303
- Spartanburg Medical Center
-
Union, South Carolina, 미국, 29379
- SMC Center for Hematology Oncology Union
-
-
South Dakota
-
Sioux Falls, South Dakota, 미국, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, 미국, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, 미국, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Chattanooga, Tennessee, 미국, 37404
- Memorial Hospital
-
Hixson, Tennessee, 미국, 37343
- Pulmonary Medicine Center of Chattanooga-Hixson
-
Ooltewah, Tennessee, 미국, 37363
- Memorial GYN Plus
-
-
Texas
-
Austin, Texas, 미국, 78701
- Dell Seton Medical Center at The University of Texas
-
Bryan, Texas, 미국, 77802
- Saint Joseph Regional Cancer Center
-
Dallas, Texas, 미국, 75235
- Parkland Memorial Hospital
-
Dallas, Texas, 미국, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
Houston, Texas, 미국, 77026-1967
- Lyndon Baines Johnson General Hospital
-
Houston, Texas, 미국, 77030
- UT MD Anderson Cancer Center
-
Houston, Texas, 미국, 77030
- Houston Methodist Hospital
-
Houston, Texas, 미국, 77070
- Methodist Willowbrook Hospital
-
Sugar Land, Texas, 미국, 77479
- Houston Methodist Sugar Land Hospital
-
-
Washington
-
Aberdeen, Washington, 미국, 98520
- Providence Regional Cancer System-Aberdeen
-
Bellevue, Washington, 미국, 98004
- Overlake Medical Center
-
Bellingham, Washington, 미국, 98225
- PeaceHealth Saint Joseph Medical Center
-
Burien, Washington, 미국, 98166
- Saint Anne Hospital
-
Centralia, Washington, 미국, 98531
- Providence Regional Cancer System-Centralia
-
Edmonds, Washington, 미국, 98026
- Swedish Cancer Institute-Edmonds
-
Enumclaw, Washington, 미국, 98022
- Saint Elizabeth Hospital
-
Everett, Washington, 미국, 98201
- Providence Regional Cancer Partnership
-
Federal Way, Washington, 미국, 98003
- Saint Francis Hospital
-
Issaquah, Washington, 미국, 98029
- Swedish Cancer Institute-Issaquah
-
Kennewick, Washington, 미국, 99336
- Kadlec Clinic Hematology and Oncology
-
Lacey, Washington, 미국, 98503
- Providence Regional Cancer System-Lacey
-
Lakewood, Washington, 미국, 98499
- Saint Clare Hospital
-
Longview, Washington, 미국, 98632
- PeaceHealth Saint John Medical Center
-
Port Townsend, Washington, 미국, 98368
- Jefferson Healthcare
-
Poulsbo, Washington, 미국, 98370
- Harrison HealthPartners Hematology and Oncology-Poulsbo
-
Renton, Washington, 미국, 98055
- Valley Medical Center
-
Seattle, Washington, 미국, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, 미국, 98122
- Swedish Medical Center-First Hill
-
Seattle, Washington, 미국, 98195
- University of Washington Medical Center - Montlake
-
Seattle, Washington, 미국, 98112
- Kaiser Permanente Washington
-
Seattle, Washington, 미국, 98104
- Pacific Gynecology Specialists
-
Seattle, Washington, 미국, 98122-5711
- Swedish Medical Center-Cherry Hill
-
Sedro-Woolley, Washington, 미국, 98284
- PeaceHealth United General Medical Center
-
Shelton, Washington, 미국, 98584
- Providence Regional Cancer System-Shelton
-
Silverdale, Washington, 미국, 98383
- Saint Joseph Medical Center Hematology and Oncology - Silverdale
-
Tacoma, Washington, 미국, 98405
- Northwest Medical Specialties PLLC
-
Tacoma, Washington, 미국, 98405
- Franciscan Research Center-Northwest Medical Plaza
-
Vancouver, Washington, 미국, 98686
- Legacy Salmon Creek Hospital
-
Vancouver, Washington, 미국, 98664
- PeaceHealth Southwest Medical Center
-
Walla Walla, Washington, 미국, 99362
- Providence Saint Mary Regional Cancer Center
-
Yakima, Washington, 미국, 98902
- North Star Lodge Cancer Center at Yakima Valley Memorial Hospital
-
Yelm, Washington, 미국, 98597
- Providence Regional Cancer System-Yelm
-
-
West Virginia
-
Charleston, West Virginia, 미국, 25304
- Vandalia Health/CAMC Institute for Academic Medicine
-
-
Wisconsin
-
Ashland, Wisconsin, 미국, 54806
- Duluth Clinic Ashland
-
Ashland, Wisconsin, 미국, 54806
- Northwest Wisconsin Cancer Center
-
Burlington, Wisconsin, 미국, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chippewa Falls, Wisconsin, 미국, 54729
- Marshfield Clinic-Chippewa Center
-
Eau Claire, Wisconsin, 미국, 54701
- Marshfield Medical Center-EC Cancer Center
-
Eau Claire, Wisconsin, 미국, 54701
- Mayo Clinic Health System-Eau Claire Clinic
-
Fond du Lac, Wisconsin, 미국, 54937
- Aurora Health Center-Fond du Lac
-
Germantown, Wisconsin, 미국, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, 미국, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, 미국, 54311
- Aurora BayCare Medical Center
-
Hayward, Wisconsin, 미국, 54843
- Essentia Health-Hayward Clinic
-
Kenosha, Wisconsin, 미국, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, 미국, 54601
- Gundersen Lutheran Medical Center
-
Ladysmith, Wisconsin, 미국, 54848
- Marshfield Medical Center - Ladysmith
-
Marinette, Wisconsin, 미국, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marshfield, Wisconsin, 미국, 54449
- Marshfield Medical Center-Marshfield
-
Milwaukee, Wisconsin, 미국, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, 미국, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, 미국, 53233
- Aurora Sinai Medical Center
-
Minocqua, Wisconsin, 미국, 54548
- Marshfield Medical Center - Minocqua
-
New Richmond, Wisconsin, 미국, 54017
- Cancer Center of Western Wisconsin
-
Oshkosh, Wisconsin, 미국, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Racine, Wisconsin, 미국, 53406
- Aurora Cancer Care-Racine
-
Rice Lake, Wisconsin, 미국, 54868
- Marshfield Medical Center-Rice Lake
-
Sheboygan, Wisconsin, 미국, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Spooner, Wisconsin, 미국, 54801
- Essentia Health-Spooner Clinic
-
Stevens Point, Wisconsin, 미국, 54482
- Marshfield Medical Center-River Region at Stevens Point
-
Summit, Wisconsin, 미국, 53066
- Aurora Medical Center in Summit
-
Superior, Wisconsin, 미국, 54880
- Essentia Health Saint Mary's Hospital - Superior
-
Two Rivers, Wisconsin, 미국, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Wausau, Wisconsin, 미국, 54401
- Marshfield Clinic-Wausau Center
-
Wauwatosa, Wisconsin, 미국, 53226
- Aurora Cancer Care-Milwaukee West
-
West Allis, Wisconsin, 미국, 53227
- Aurora West Allis Medical Center
-
Weston, Wisconsin, 미국, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, 미국, 54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Wyoming
-
Cheyenne, Wyoming, 미국, 82001
- Cheyenne Regional Medical Center-West
-
Cody, Wyoming, 미국, 82414
- Billings Clinic-Cody
-
Sheridan, Wyoming, 미국, 82801
- Welch Cancer Center
-
-
-
-
Ontario
-
Toronto, Ontario, 캐나다, M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
-
Patients must have recurrent or persistent endometrial carcinoma, which is refractory to curative therapy or established treatments; histologic confirmation of the original primary tumor is required; patients with the following histologic epithelial cell types are eligible: endometrioid adenocarcinoma, serous adenocarcinoma, undifferentiated carcinoma, mixed epithelial carcinoma, adenocarcinoma not otherwise specified (N.O.S.); NOTE: clear cell and carcinosarcoma histology is excluded.
-
Patients must have measurable disease as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or non-measurable (detectable) disease
-
Measurable disease is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded); each lesion must be >= 10 mm when measured by computed tomography (CT), magnetic resonance imaging (MRI) or caliper measurement by clinical exam; or >= 20 mm when measured by chest x-ray; lymph nodes must be > 15 mm in short axis when measured by CT or MRI; patients with measurable disease must have at least one "target lesion" to be used to assess response on this protocol as defined by RECIST version 1.1; tumors within a previously irradiated field will be designated as "non-target" lesions unless progression is documented or a biopsy is obtained to confirm persistence at least 90 days following completion of radiation therapy
-
Non-measurable (detectable) disease in a patient is defined in this protocol as one who does not have measurable disease but has at least one of the following conditions:
- Ascites and/or pleural effusion attributed to tumor;
- Solid and/or cystic abnormalities on radiographic imaging that do not meet RECIST 1.1 definitions for target lesions.
-
-
Patients must have signed an approved informed consent and authorization permitting release of personal health information.
-
Patients must have had one prior chemotherapeutic regimen for management of endometrial carcinoma; initial treatment may include chemotherapy, chemotherapy and radiation therapy, and/or consolidation/maintenance therapy; chemotherapy administered in conjunction with primary radiation as a radio-sensitizer WILL be counted as a systemic chemotherapy regimen.
-
Patients are allowed to receive, but are not required to receive, one additional cytotoxic regimen for management of recurrent or persistent disease according to the following definition: cytotoxic regimens include any agent that targets the genetic and/or mitotic apparatus of dividing cells, resulting in dose-limiting toxicity to the bone marrow and/or gastrointestinal mucosa; Note: patients on this non-cytotoxic study are allowed to receive one additional cytotoxic chemotherapy regimen for management of recurrent or persistent disease, as defined above; however, patients are encouraged to enroll on second-line non-cytotoxic studies prior to receiving additional cytotoxic therapy.
-
Patients may have received non cytotoxic therapy including immunotherapy (1 prior line in either upfront or recurrent setting) but excluding cediranib, olaparib, AZD5363 (capivasertib), durvalumab (MEDI4736), or the combination of lenvatinib and pembrolizumab for the management of recurrent or persistent disease; prior hormonal therapy is allowed; hormonal therapy for grade 1 endometrial cancers with low volume or indolent disease is encouraged.
-
Bevacizumab, or one course of single-agent immune-checkpoint therapy, excluding durvalumab (MEDI4736), is permitted prior to enrollment on this trial.
-
Body weight > 30 kg.
-
Age >= 18.
-
The trial is open to females only (including women with an intact uterus with uterine cancer); fertile females of childbearing potential need to agree to use adequate contraceptive measures from 2 weeks prior to the study and until 1 month after study treatment discontinuation, and have a negative serum or urine pregnancy test within 3 days prior to the start of study treatment.
-
Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0,1 or 2 (Karnofsky >= 60%) within 7 days prior to registration; patients should have no deterioration over the previous two weeks.
-
Hemoglobin >= 10 mg/dL with no blood transfusion in the past 28 days (within 28 days prior to administration of study drug).
-
Platelet count >= 100 x 10^9/L (within 28 days prior to administration of study drug).
-
Absolute neutrophil count (ANC) >= 1.5 x 10^9/L (within 28 days prior to administration of study drug).
-
Patients must have creatinine clearance estimated of >= 51 mL/min using the Cockcroft Gault equation or based on a 24-hour urine test (within 28 days prior to administration of study drug).
-
Serum bilirubin =< 1.5 X upper limit of normal (ULN) (within 28 days prior to administration of study drug).
-
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3 x ULN (within 28 days prior to administration of study drug).
-
Urinalysis (dipstick) =< 1+ proteinuria OR urine protein creatinine ratio (UPCR) < 1 (within 28 days prior to administration of study drug).
-
Patients must be able to swallow and retain oral medications and without gastrointestinal illnesses that would preclude absorption of cediranib, olaparib, or AZD5363 (capivasertib).
-
Patients must have adequately controlled blood pressure (BP), with a BP no greater than 140 mmHg (systolic) and 90 mmHg (diastolic) for eligibility; patients must have a BP of =< 140/90 mmHg taken in the clinic setting by a medical professional within 2 weeks prior to starting study; patients with hypertension may be managed with up to a maximum of three antihypertensive medications; it is strongly recommended that patients who are on three antihypertensive medications be followed by a cardiologist or blood pressure specialist for management of blood pressure while on protocol.
- Note: Patients must be willing and able to check and record daily blood pressure readings.
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry.
-
Adequately controlled thyroid function, with no symptoms of thyroid dysfunction.
-
Postmenopausal or evidence of non-childbearing status for women of childbearing potential as confirmed by a negative urine or serum pregnancy test within 7 days prior to start of investigational products (IPs); postmenopausal is defined as:
-
Age >= 60 years, or
-
Age < 60 with any one or more of the conditions below:
- Amenorrheic for >= 1 year in the absence of chemotherapy and/or hormonal treatments,
- Luteinizing hormone and/or follicle stimulating hormone and/or estradiol levels in the post-menopausal range
- Radiation-induced oophorectomy with last menses > 1 year ago,
- Chemotherapy-induced menopause with > 1 year interval since last menses,
- Surgical sterilization (bilateral oophorectomy or hysterectomy).
-
-
Patients must have a life expectancy of greater than 16 weeks.
-
Patients with a previous diagnosis of immune or inflammatory colitis or chronic diarrhea > 1 month without immune or inflammatory colitis are eligible with adequately controlled colitis (no diarrhea greater than grade 1 for at least 28 days) and in the absence of symptoms related to colonic dysfunction; patients who required steroids for prior immune related colitis are not eligible.
-
Females of child-bearing potential should use two forms of highly reliable methods of contraception from the time of screening until 4 weeks after discontinuing study treatment.
-
Acceptable methods of contraception include:
- Established use of oral, injected or implanted hormonal methods of contraception.
- Placement of an intrauterine device or intrauterine system.
- Barrier methods of contraception: condom or occlusive cap (diaphragm or cervical/vault caps) with spermicidal foam/gel/film/cream/suppository.
- Male partner sterilization (with the appropriate post-vasectomy documentation of the absence of sperm in the ejaculate).
- True abstinence (i.e., not engaging in sexual activity for the total duration of study treatment and the treatment washout period is an acceptable practice; however, periodic abstinence, the rhythm method, and the withdrawal method are not acceptable methods of birth control).
- Bilateral tubal occlusion or salpingectomy
-
Acceptable non-hormonal birth control methods include:
- Total/True abstinence: When the patient refrains from any form of sexual intercourse and this is in line with their usual and/or preferred lifestyle; this must continue for the total duration of the trial and for at least 1 month after the last dose of study drug <<for 3 months after last dose for male patients>>. [Periodic abstinence (e.g., calendar, ovulation, symptothermal, post-ovulation methods, or declaration of abstinence solely for the duration of a trial) and withdrawal are not acceptable methods of contraception]
- Vasectomised sexual partner PLUS male condom. With participant assurance that partner received post-vasectomy confirmation of azoospermia.
- Tubal occlusion PLUS male condom
- Intrauterine device (IUD) PLUS male condom. Provided coils are copper-banded.
-
Acceptable hormonal methods:
- Normal and low dose combined oral pills PLUS male condom.
- Cerazette (desogestrel) PLUS male condom. Cerazette is currently the only highly efficacious progesterone-based pill.
- Hormonal shot or injection (e.g., Depo-Provera) PLUS male condom.
- Etonogestrel implants (e.g., Implanon, Norplant) PLUS male condom.
- Norelgestromin/EE transdermal system PLUS male condom
- Intrauterine system [IUS] device (e.g., levonorgestrel releasing IUS -Mirena) PLUS male condom.
- Intravaginal device (e.g., EE and etonogestrel) PLUS male condom.
-
Exclusion Criteria:
-
Prior enrollment into a clinical trial including cediranib or olaparib; Note: prior bevacizumab is not an exclusion criterion.
-
Prior enrollment into a clinical trial including cediranib, olaparib, AZD5363 (capivasertib), durvalumab (MEDI4736), or the combination of lenvatinib and pembrolizumab. Note: Prior bevacizumab or single-agent immune checkpoint blockade, excluding durvalumab (MEDI4736), is not an exclusion criterion.
-
Prior chemotherapy, endocrine therapy, radiotherapy, or investigational agents within 4 weeks.
-
More than one prior line of treatment with immune checkpoint blockade therapy.
-
Current signs/symptoms of bowel obstruction and/or signs/symptoms of bowel obstruction within the preceding 3 months.
-
History of gastrointestinal perforation; patients with a history of abdominal fistula will be considered eligible if the fistula was surgically repaired or has healed, there has been no evidence of fistula for at least 6 months, and patient is deemed to be at low risk of recurrent fistula.
-
Uncontrolled intercurrent illness including, but not limited to known ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, extensive interstitial bilateral lung disease on high resolution computed tomography (HRCT) scan or psychiatric illness/social situations that would limit compliance with study requirements.
-
Concomitant use of known strong cytochrome (CYP) 3A inhibitors (e.g., itraconazole, telithromycin, clarithromycin, protease inhibitors boosted with ritonavir or cobicistat, indinavir, saquinavir, nelfinavir, boceprevir, telaprevir) or moderate CYP3A inhibitors (e.g. ciprofloxacin, erythromycin, diltiazem, fluconazole, verapamil); the required washout period prior to starting study treatments is 2 weeks for strong inhibitors, and at least 1 week for moderate inhibitors.
-
Concomitant use of potent inhibitors or inducers of CYP3A4 within 2 weeks before the start of study treatment (3 weeks for St John's wort), or sensitive substrates of CYP3A4, CYP2C9 and/or CYP2D6 with a narrow therapeutic window within 1 week before the start of study treatment. Concomitant use of drugs known to prolong the QT interval within 5 half-lives of the first dose of study treatment.
-
Pregnant women are excluded from this study because cediranib and olaparib are agents with the potential for teratogenic or abortifacient effects; because there is an unknown but potential risk of adverse events in nursing infants secondary to treatment of the mother with cediranib and olaparib, breastfeeding should be discontinued if the mother is treated with cediranib or olaparib; these potential risks may also apply to other agents used in this study; for women of childbearing capacity a negative pregnancy test is required.
-
Known human immunodeficiency virus (HIV)-positive individuals are ineligible because of the potential for pharmacokinetic interactions between many anti-HIV drugs and cediranib, olaparib, and/or AZD5363 (capivasertib); in addition, these individuals are at increased risk of lethal infections when treated with marrow-suppressive therapy.
-
Known active hepatitis B or hepatitis C infection on antiviral treatment.
-
Prior history of stroke or transient ischemic attack within the last 6 months.
-
Left ventricular ejection fraction (LVEF) < lower limit of normal (LLN) per institutional guidelines, or < 55%, if threshold for normal not otherwise specified by institutional guidelines, for patients with the following risk factors:
- Prior treatment with anthracyclines
- Prior treatment with trastuzumab
- Prior central thoracic radiation therapy (RT), including exposure of heart to therapeutic doses of ionizing RT
- History of myocardial infarction within 6-12 months prior to start of IPs
- Prior history of other significant impaired cardiac function.
-
Patients with any of the following:
- History of myocardial infarction within 6 months prior to starting treatment
- Unstable angina
- Resting electrocardiogram (ECG) with clinically significant abnormal findings or with corrected QT interval (QTc) > 470 msec on 2 or more time points within a 24 hour period or family history of long QT syndrome
- New York Heart Association functional classification of III or IV.
-
Prior history of hypertensive crisis or hypertensive encephalopathy.
-
Major surgical procedure within 4 weeks prior to starting treatment; patients must have recovered from any effects of any major surgery and surgical wound should have healed prior to starting treatment.
-
History of intra-abdominal abscess within 3 months prior to starting treatment.
-
Patients may not use any complementary or alternative medicines including natural herbal products or folk remedies as they may interfere with the effectiveness of the study treatments.
-
No prior allogeneic bone marrow transplant or double umbilical cord blood transplantation (dUBCT).
-
Whole blood transfusions in the last 120 days prior to entry to the study (packed red blood cells and platelet transfusions are acceptable).
-
Patients with myelodysplastic syndrome (MDS)/treatment-related acute myeloid leukemia (t-AML) or with features suggestive of MDS/AML.
-
Central nervous system metastases:
- Symptomatic uncontrolled brain metastases requiring corticosteroid treatment; history of spinal cord compression unless after definitive treatment the patient has clinically stable disease (SD) for at least 28 days prior to starting IPs; in the absence of these features and in an asymptomatic patient a scan to confirm the absence of brain metastases is not required.
-
Other malignancy within the last 5 years except for:
- Curatively treated basal cell or squamous cell carcinoma of skin; in situ cancer of the cervix, ductal carcinoma in situ of the breast or stage 1, grade 1 endometrial carcinoma
- Curatively treated other solid tumors including lymphomas (without bone marrow involvement) with no evidence of disease for >= 5 years prior to start of IPs.
-
Persisting >= grade 2 Common Terminology Criteria for Adverse Events (CTCAE) toxicity (except alopecia and grade 2 peripheral neuropathy) from previous anti-cancer treatment(s).
-
History of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib, olaparib, AZD5363 (capivasertib), or durvalumab (MEDI4736).
-
Pneumonitis or moderate-severe pre-existing pulmonary disease.
-
Patients who have a diagnosis of immunodeficiency or are receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days of enrollment.
- Premedication with steroids for CT scan contrast is allowed.
- Inhaled or topical corticosteroids are allowed.
- The use of mineralocorticoids (e.g., fludrocortisone) for patients with orthostatic hypotension or adrenocortical insufficiency is allowed.
- The use of physiologic doses of corticosteroids may be approved after consultation with the study chair.
-
Patients with active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including systemic corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as SLE, connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease.
-
Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible.
-
Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), anti-thyroid antibodies should be evaluated for the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible.
-
Active infection including tuberculosis (clinical evaluation that includes clinical history, physical examination and radiographic findings, and tuberculosis [TB] testing in line with local practice).
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
실험적: Arm I (cediranib maleate_reference group 1)
Patients in reference group 1 receive cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
|
실험적: Arm II (olaparib)
Patients receive olaparib PO BID. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
|
실험적: Arm III (cediranib maleate, olaparib)
Patients receive olaparib PO BID and cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Given PO
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
|
실험적: Arm IV (olaparib, capivasertib)
Patients receive olaparib PO BID on days 1-28 and capivasertib PO BID on days 1-4 each week. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Given PO
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
|
실험적: Arm V (olaparib, durvalumab)
Patients receive olaparib PO BID on days 1-28 and durvalumab IV on day 1. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Given IV
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
|
실험적: Arm VI (cediranib maleate, durvalumab)
Patients receive cediranib maleate PO QD on days 1-5 each week and durvalumab IV on day 1 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Given IV
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
|
실험적: Arm VII (cediranib maleate_reference group 2)
Patients in reference group 1 receive cediranib maleate PO QD. Cycles repeat every 28 days in the absence of disease progression or unaccepted toxicity. Additionally, patients undergo blood sample collection, bone marrow aspiration and biopsy, CT, Echo or MUGA on study. |
Undergo blood sample collection
다른 이름들:
Undergo MUGA
다른 이름들:
Undergo CT scan
다른 이름들:
Given PO
다른 이름들:
Undergo bone marrow aspiration and biopsy
다른 이름들:
Undergo Echo
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Progression-free Survival
기간: Scans were done every 8 weeks for the first year and then every 12 weeks thereafter until disease progression. Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
Progression-free survival is defined as the time from the date of study enrollment to the investigator-determined date of progression or death due to any cause, whichever occurs first. For individuals who are alive and progression-free, the censored time at risk will be defined as the time from the study enrollment date to the date of the patient's last radiographic disease assessment. |
Scans were done every 8 weeks for the first year and then every 12 weeks thereafter until disease progression. Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Overall Survival
기간: Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
Overall survival is defined as the time from the date of study enrollment to the date of death regardless of cause. For those individuals who have no death reported at the time of the analysis, the censored time at risk will be assessed from the date of study enrollment to the date that the patient was last contacted and known to be alive. |
Vital status was assessed every 3 months for 2 years and then every 6 months for 3 years (5-years total).
|
|
Objective Tumor Response
기간: Scans were done every 8 weeks for the first year; then every 12 weeks thereafter until disease progression is confirmed or up to 33 months.
|
Objective tumor response was assessed in patients with measurable disease by the site investigator using RECIST v1.1. Patients with complete or partial tumor response were considered to have a response. |
Scans were done every 8 weeks for the first year; then every 12 weeks thereafter until disease progression is confirmed or up to 33 months.
|
|
Incidence of Adverse Events
기간: Toxicity was assessed every other week for the first 8 weeks of study therapy and every 8 weeks after the completion or termination of study therapy up to 50 months.
|
The number of patients who reported at least a grade 3 adverse event were assessed in those who initiated treatment. |
Toxicity was assessed every other week for the first 8 weeks of study therapy and every 8 weeks after the completion or termination of study therapy up to 50 months.
|
기타 결과 측정
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
데 옥시 리보 핵산 (DNA) 상 동성 복구 유전자의 돌연변이
기간: 최대 5 년
|
최대 5 년
|
|
|
Markers of Angiogenesis in Serial Plasma Samples
기간: Up to 5 years
|
Will assess if markers of angiogenesis in serial plasma samples are associated with response to cediranib alone or in combination with olaparib. |
Up to 5 years
|
공동 작업자 및 조사자
협력자
협력자
수사관
수사관
- 수석 연구원: Helen J Mackay, NRG Oncology
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (실제)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
- 비뇨생식기 질환
- 생식기 질환
- 내분비계 질환
- 비뇨생식기 신생물
- 부위별 신생물
- 신생물
- 여성 비뇨 생식기 질환
- 여성 비뇨 생식기 질환 및 임신 합병증
- 조직학적 유형에 따른 신생물
- 생식기 질환, 여성
- 신생물, 선상 및 상피
- 선암종
- 난소 질환
- 부속기 질환
- 생식기 신생물, 여성
- 생식선 장애
- 암종
- 자궁 신생물
- 육종
- 신생물, 결합 및 연조직
- 신생물, 복합 및 혼합
- 자궁내막 신생물
- 난소 신생물
- 암육종
- 암종, 자궁내막양
- 아미노산, 펩티드 및 단백질
- 단백질
- 황 화합물
- 유기 화학 물질
- 조사 기술
- 치료학
- 임상 실험실 기술
- 진단 기술 및 절차
- 진단
- 수술 절차, 수술
- 약물 요법
- 세포 학적 기술
- 세포 진단
- 항체
- 면역 글로불린
- 면역 단백질
- 혈액 단백질
- 혈청 글로불린
- 글로불린
- 무기 화학 물질
- 진단 기술, 수술
- 면역 글로불린 이소 타입
- 황화물
- 음이온
- 이온
- 전해질
- 황화수소
- 면역글로불린 G
- 생검
- 시편 처리
- capivasertib
- Durvalumab
- 이황화
- 올라 파리브
- 세디 라 닙
- 체액 요법
기타 연구 ID 번호
기타 연구 ID 번호
- NCI-2017-01672
- U10CA180868 (미국 NIH 보조금/계약)
- NCI-2017-01672 (레지스트리 식별자: CTRP (Clinical Trial Reporting Program))
- NRG-GY012 (기타 식별자: CTEP)
- NRG-GY012 (기타 식별자: NRG Oncology)
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .